Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02512835 · ClinicalTrials.gov registry record

Understanding the Value of Community Vital Signs in Primary Care

A clinical trial of Breast Cancer and Prostate Cancer, sponsored by Virginia Commonwealth University.

Completed
Registry status
120
Enrollment target
2
Study locations

NCT02512835: Completed study of Breast Cancer and Prostate Cancer, sponsored by Virginia Commonwealth University.

NCT02512835 is a study of Breast Cancer and Prostate Cancer that has completed, run by Virginia Commonwealth University. The registered enrollment target is 120 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02512835, a study of Breast Cancer and Prostate Cancer, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
120 participants
Enrollment target
2
Study locations

Study Summary

Social determinants of health (e.g. the income, education, and environment of patients) may exert greater influence on health outcomes than traditional clinical factors (e.g. lab results, diagnoses, and family history). Calls for integrating primary care and public health are therefore increasing, but merging these domains of care is logistically difficult. Research is lacking on the incremental benefit of adding public health data at the practice level-- in improving either health outcomes or care delivery. This proof of concept pilot will merge data from electronic health records (EHRs) with community vital signs, a set of metrics that describes key community resources that affect health. The investigators will identify resource poor communities, or cold spots, based on four variables (education, poverty, life expectancy, and access to healthy foods) at the census tract level - referred to as a community vital sign. The hypothesis is that patients coming from cold spots are more likely to have worse health outcomes and that clinicians will deliver better care if they know a patient's community context and his/her specific social needs. This study will involve 12 primary care practices in Northern Virginia that care for more than 170,000 patients. Patient addresses will be geocoded for each practice and determine which patients reside in cold spots for each community vital sign. The variation for each community vital sign for each practice's patients will be calculated and a bivariate and regression analyses will be used to determine whether coming from a cold spot is associated with worse clinical quality metrics. 15 clinicians will be alerted when they see a patient from a cold spot, patients will complete a social needs survey, and clinicians will prospectively document through surveys whether such knowledge affects interpersonal interactions (such as time spent with patients and the use of clearer language) or clinical management (such as referrals to care coor

Primary Outcome

Likelihood patient living in a cold spot received recommended cancer screening and cardiovascular preventive care based on National Committee for Quality Assurance (NCQA) quality measures.

Interventions

  • OTHER Community vital signs

Study Locations (2)

Virginia

  • Fairfax Family Practice Centers - Fairfax
  • Virginia Ambulatory Care Outcomes Research Network - Richmond

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2015-10
Est. Completion 2016-11-01
Virginia Commonwealth University

558 total trials

What the finished NCT02512835 record still lists

NCT02512835 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower).

The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Community vital signs is the first listed.

NCT02512835 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT02512835 about?

NCT02512835 is a clinical study titled "Understanding the Value of Community Vital Signs in Primary Care". Social determinants of health (e.g. the income, education, and environment of patients) may exert greater influence on health outcomes than traditional clinical factors (e.g. lab results, diagnoses, and family history). Calls for integrating primary care and public health are therefore increasing, b...

What is the current status of trial NCT02512835?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2015-10. Estimated completion is 2016-11-01.

What conditions does trial NCT02512835 study?

This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Cervical Cancer, Cardiovascular Disease, Colon Cancer.

What interventions are being tested in trial NCT02512835?

The interventions under investigation include: Community vital signs (OTHER).

Who is sponsoring clinical trial NCT02512835?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02512835 being conducted?

This trial has 2 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02512835's enrollment target sits among peer trials

120 510th of 1224 higher than 703 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02512835, the US trial registry maintained by the National Library of Medicine. NCT02512835 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.